Search details
1.
The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy.
J Infect Dis
; 229(3): 743-752, 2024 Mar 14.
Article
in English
| MEDLINE | ID: mdl-38349333
2.
Processing laboratory considerations for multi-center cellular therapy clinical trials: a report from the Consortium for Pediatric Cellular Immunotherapy.
Cytotherapy
; 23(2): 157-164, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33189573
3.
Critical testing and parameters for consideration when manufacturing and evaluating tumor-associated antigen-specific T cells.
Cytotherapy
; 21(3): 278-288, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30929992
4.
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication.
Nat Commun
; 15(1): 2749, 2024 Mar 29.
Article
in English
| MEDLINE | ID: mdl-38553461
5.
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.
Blood Adv
; 8(5): 1116-1127, 2024 Mar 12.
Article
in English
| MEDLINE | ID: mdl-38163318
6.
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.
Nat Commun
; 15(1): 3258, 2024 Apr 18.
Article
in English
| MEDLINE | ID: mdl-38637498
7.
Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease.
Blood Adv
; 7(10): 2105-2116, 2023 05 23.
Article
in English
| MEDLINE | ID: mdl-36516084
8.
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.
Blood Adv
; 6(8): 2520-2534, 2022 04 26.
Article
in English
| MEDLINE | ID: mdl-35244681
Results
1 -
8
de 8
1
Next >
>>